ANTIPLATELET THERAPY AFTER PCI. 2021 ACC/AHA/SCAI GUIDELINES

ANTIPLATELET THERAPY BEFORE / DURING & AFTER PCI and CABG - 2021 ACC/AHA/SCAI GUIDELINES. A lot has changed in the field of Antiplatelet and antithrombotic therapy in patients undergoing #PCI or CABG. New evidence from trials like TWILIGHT trial, STOPDAPT trial, GLASSY & GLOBAL LEADER trial has made us reconsider what is optimal Antiplatelet Therapy for patients undergoing CABG and PCI. The new ACC/ AHA/ SCAI Guidelines have considered these evidence and have given new recommendations for patients undergoing #coronary revascularization. Let's take a deep dive into the topic. We have discussed 2021 ACC/AHA/SCAI GUIDELINES under various headings in the following videos and podcast. Do have a look. Revascularization in STEMI    • Revascularization in STEMI. 2021 ACC/ AHA/...   Revascularization in NSTE-ACS    • Revascularization in NSTE-ACS. 2021 ACC/AH...   Revascularization in stable CAD    • Revascularization - stable CAD. ACC/AHA/SC...